Literature DB >> 8750810

Hyponatraemia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna.

M Schwab1, D Wenzel, H Ruder.   

Abstract

UNLABELLED: Desmopressin (DDAVP) is frequently used in the treatment of primary isolated enuresis nocturna if other approaches have failed. We report a further case of hyponatraemia and cerebral convulsion due to water intoxication after intranasal DDAVP application by a 6 year-old boy with enuresis.
CONCLUSION: Although adverse reactions in DDAVP (e.g. hyponatraemia) are rare, it should not be considered as the first choice treatment of enuresis nocturna and only be used with caution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8750810     DOI: 10.1007/bf02115626

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study.

Authors:  U B Knudsen; S Rittig; J P Nørgaard; J B Lundemose; E B Pedersen; J C Djurhuus
Journal:  Urol Res       Date:  1991

2.  Dangers of intranasal desmopressin for nocturnal enuresis.

Authors:  M F Bamford; G Cruickshank
Journal:  J R Coll Gen Pract       Date:  1989-08

3.  Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus.

Authors:  I Vávra; A Machová; V Holecek; J H Cort; M Zaoral; F Sorm
Journal:  Lancet       Date:  1968-05-04       Impact factor: 79.321

4.  Desmopressin acetate in children with severe primary nocturnal enuresis.

Authors:  K Miller; G T Klauber
Journal:  Clin Ther       Date:  1990 Jul-Aug       Impact factor: 3.393

Review 5.  Enuresis nocturna: long term use and safety aspects of minrin (desmopressin) spray.

Authors:  R N Sukhai
Journal:  Regul Pept       Date:  1993-04-29

6.  Desmopressin in nocturnal enuresis.

Authors:  M Aladjem; R Wohl; H Boichis; S Orda; D Lotan; S Freedman
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

Review 7.  Desmopressin acetate and nocturnal enuresis: how much do we know?

Authors:  M E Moffatt; S Harlos; A J Kirshen; L Burd
Journal:  Pediatrics       Date:  1993-09       Impact factor: 7.124

Review 8.  Drug therapy for nocturnal enuresis. Current treatment recommendations.

Authors:  K Miller; B Atkin; M L Moody
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

9.  Comparison of desmopressin and enuresis alarm for nocturnal enuresis.

Authors:  S Wille
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

10.  Pharmacokinetics and haematological effects of desmopressin.

Authors:  M Köhler; A Harris
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more
  3 in total

1.  Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis.

Authors:  D C Apakama; A Bleetman
Journal:  J Accid Emerg Med       Date:  1999-05

Review 2.  Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.

Authors:  T Y Chan
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 3.  Comparative tolerability of drug treatment for nocturnal enuresis in children.

Authors:  Dominik Müller; Charles C Roehr; Paul Eggert
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.